Table 4 Dose for each individual (in g) at different scheduled intervals (14 or 21 days) to obtain appropriate serum AAT concentrations during 85% of the interval between doses.
Patient no | Previous dose | D14/85 | D21/85 | ΔD21/85 (%) |
---|---|---|---|---|
1 | 12 g/21 days | 10* | 20 | 25 |
2 | 10 g/21 days | 6 | 14* | 40 |
3 | 13 g/21 days | 8 | 14* | 7.7 |
4 | 11 g/21 days | 6 | 11* | 0 |
5 | 12 g/21 days | 7 | 14* | 17 |
6 | 11 g/21 days | 5 | 11* | 0 |
*Selected dosage regimen for each patient.